Alessandro M. Vannucchi
Andreas Reiter
Deepti H Radia
Johannes LübkeSymposium | Disease biology and molecular architecture in advanced systemic mastocytosis
During the MPN Hub symposium at the EHA2026 Congress, Deepti H Radia discussed disease biology and molecular architecture in advanced systemic mastocytosis.
All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional. If you are a patient or carer, please visit the MPN Advocates Network.
TRANSLATE
The MPN Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the MPN Hub cannot guarantee the accuracy of translated content. The MPN Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The MPN Hub is an independent medical education platform, sponsored by GSK, Novartis, AOP, Sobi and Takeda and supported through independent educational grants from Bristol Myers Squibb, Blueprint, Incyte and Merck Sharp & Dohme LLC, Rahway, NJ, USA. Funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account to access:
Bookmark & personalize site content
Receive alerts for new content in your areas of interest
View MPN content recommended for you
Symposium series | Advanced systemic mastocytosis: Redefining the disease, rethinking patient outcomes
On June 12, 2026, the MPN Hub held a live symposium at the European Hematology Association (EHA) 2026 Congress, Stockholm, SE, titled Advanced systemic mastocytosis: Redefining the disease, rethinking patient outcomes. The symposium was chaired by Deepti H. Radia, with presentations from Andreas Reiter, Johannes Lübke, and Alessandro Vannucchi, and included a Q&A session with live audience participation. Explore each session below:
Symposium series | Advanced systemic mastocytosis: Redefining the disease, rethinking patient outcomes
Symposium | Advanced systemic mastocytosis: Clinical challenges and unmet needs
During the MPN Hub symposium at the EHA2026 Congress, Andreas Reiter discussed the clinical challenges and unmet needs in advanced systemic mastocytosis.
Symposium | Advanced systemic mastocytosis: Diagnosis, risk stratification, and response assessment in 2026
During the MPN Hub symposium at the EHA2026 Congress, Johannes Lübke discussed diagnosis, prognostic risk stratification, and response assessment in advanced systemic mastocytosis.
Symposium | Advanced systemic mastocytosis therapeutic landscape: Evidence-based strategies across the disease spectrum
During the MPN Hub symposium at EHA 2026, Alessandro Vannucchi reviewed the evolving therapeutic landscape in advanced systemic mastocytosis, including treatment selection across disease subtypes and emerging therapeutic approaches.
Symposium | Looking ahead: Future directions and unanswered questions in advanced systemic mastocytosis (panel discussion and Q&A)
During the MPN Hub symposium at the EHA2026 Congress, Deepti H Radia chaired a panel Q&A session focused on future directions and unanswered questions in advanced systemic mastocytosis.
This educational resource is independently supported by Blueprint Medicines. All content is developed by the faculty in collaboration with SES. Funders are allowed no influence.
Please indicate your level of agreement with the following statements:
The content was clear and easy to understand
The content addressed the learning objectives
The content was relevant to my practice
I will change my clinical practice as a result of this content